SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib
Drug major Sun Pharma on Wednesday said it has inked a licensing agreement with Sun Pharma Advanced Research Company to commercialise a medication for the treatment of neonatal seizures in the US market. The Mumbai-based drug maker has inked a pact with Sun Pharma Advanced Research Company (SPARC) to commercialise benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the US.
Sun Pharma Advanced Research Company (SPARC) today announced that it nhas entered into an agreement with Visiox Pharma to grant exclusive nworldwide rights (except for India and Greater China) for the ndevelopment and commercialisation of PDP-716 and SDN-037.